The purpose of this study is to determine whether disease management program is effective in preventing acute exacerbations in patients with unstable chronic obstructive pulmonary disease (COPD) or asthma.
The aim of the present study is to test the efficacy of a comprehensive community disease management program in patients with unstable chronic obstructive pulmonary disease (COPD) or asthma. The intervention is delivered by designated nurses and pulmonologists, in collaboration with the primary practitioners and other healthcare professionals at the community, in the Jerusalem and the Lowland District of Maccabi Health Services in Israel. The main purpose is to evaluate the effect of the intervention on the use acute care and emergency health services for acute exacerbation of the lung disease. Secondary objectives include the evaluation of the effect of the intervention on quality of life, physical function, pulmonary function test, depression and all-cause mortality.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
492
Comprehensive pulmonary care including patient education of self-care, coordination of care, monitoring of patient adherence, providing advice in acute exacerbations
Pulmonary disease is managed by the primary practitioner and a consultant pulmonologist
Maccabi Pulmonary Clinic
Bat Yam, Israel
Maccabi Pulmonary Clinic
Holon, Israel
Healthcare services utilization for acute exacerbations of pulmonary disease
The proportion of patients who, due to exacerbation of their COPD or asthma, have at least one out of hours visit to a "off-hour non-hospital based acute-care facilities", or a visit to a hospital emergency room, or a hospitalization within the two years of follow-up.
Time frame: Every 6 months during 1-3 years' follow-up
Quality of life
Health-related quality of life
Time frame: Every 6 months during 1-3 years' follow-up
Pulmonary function tests
Pulmonary function tests
Time frame: Every 6 months during 1-3 years' follow-up
Physical function
6-minutes walk test assessment
Time frame: Every 6 months during 1-3 years' follow-up
Depression
PHQ-9 Questionnaire
Time frame: Every 6 months during 1-3 years' follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.